← Back to directory

Gregory W. Albers

Researcher Next ID · RN-026114

Researcher · Medicine

Palo Alto University

Palo Alto, Belgium

Not currently recruitingFunding unknown
Works count
1,073
Citation count
87,780
H-index
136
i10-index
535

Research interests

Medicine
Acute Ischemic Stroke Management
Cerebrovascular and Carotid Artery Diseases
Stroke Rehabilitation and Recovery
Venous Thromboembolism Diagnosis and Management
Advanced MRI Techniques and Applications

Publications

  • Trial of Endovascular Thrombectomy for Large Ischemic Strokes

    New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2214403

  • Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging

    New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1713973

  • One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke

    New England Journal of Medicine · 2016 · 10.1056/nejmoa1412981

  • Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke

    New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1415061

  • Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

    The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)60584-5

  • Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke

    Stroke · 2013 · https://doi.org/10.1161/strokeaha.113.001972

  • MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study

    The Lancet Neurology · 2012 · 10.1016/s1474-4422(12)70203-x

  • Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial

    The Lancet · 2012 · 10.1016/s0140-6736(12)61299-9

  • Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

    New England Journal of Medicine · 2012 · 10.1056/nejmoa1009639

  • Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

    The Lancet · 2010 · 10.1016/s0140-6736(10)60491-6

  • Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack

    Stroke · 2010 · 10.1161/str.0b013e3181f7d043

  • Definition and Evaluation of Transient Ischemic Attack

    Stroke · 2009 · 10.1161/strokeaha.108.192218

  • Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

    New England Journal of Medicine · 2008 · 10.1056/nejmoa0805002

  • Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

    New England Journal of Medicine · 2008 · 10.1056/nejmoa0804593

  • Antithrombotic Therapy in Atrial Fibrillation

    CHEST Journal · 2008 · 10.1378/chest.08-0678

  • Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack

    Stroke · 2006 · 10.1161/01.str.0000199147.30016.74

  • Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study

    Annals of Neurology · 2006 · 10.1002/ana.20976

  • Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation

    JAMA · 2005 · 10.1001/jama.293.6.690

  • The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)

    Stroke · 2004 · 10.1161/01.str.0000149938.08731.2c

  • Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

    The Lancet · 2004 · 10.1016/s0140-6736(04)15692-4

  • Transient Ischemic Attack — Proposal for a New Definition

    New England Journal of Medicine · 2002 · 10.1056/nejmsb020987

  • A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke

    New England Journal of Medicine · 2001 · 10.1056/nejmoa011258

  • Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke

    JAMA · 2000 · 10.1001/jama.283.9.1145

  • Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset

    JAMA · 1999 · 10.1001/jama.282.21.2019

  • Antithrombotic and Thrombolytic Therapy for Ischemic Stroke

    CHEST Journal · 1998 · 10.1378/chest.114.5_supplement.683s

Current projects

    No projects listed.